--- title: 'Director, Quality Control Operations at Vaxcyte' canonical: 'https://feeny.ai/job/director-quality-control-operations-vaxcyte-visp-valais-se41wa0bkvjx' type: 'job' last_seen: '2026-11-02' --- # Director, Quality Control Operations at Vaxcyte - **Company:** Vaxcyte - **Location:** Visp Valais, Switzerland - **Posted:** 2026-10-28 - **Last confirmed live:** 2026-11-02 - **Apply:** https://boards.greenhouse.io/vaxcyte/jobs/5464246008?gh_jid=5464246008 ## Job description Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE:  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Director of QC Operations leads the QC Operations team and is accountable for day-to-day Quality Control execution across Vaxcyte contract manufacturing and contract testing network. The role ensures the current business has the QC support it needs, that testing and release happen on time, and that Quality Control operates in a compliant, inspection-ready state through VAX-31 BLA and into commercial supply. As the executive function of Quality Control, the role provides leadership and oversight for implementation of the approved analytical control strategy and specifications at the contract manufacturing and contract testing organizations. Working closely with Analytical Development, Analytical Science and Technology, Stability, Quality Assurance, Regulatory Affairs, and the Analytical Technical Leads, this role is critical to timely, compliant, and uninterrupted release of Vaxcyte products. Essential Functions: - Day-to-Day QC Execution and Release - Leads the QC Operations team and is accountable for sample flow, testing schedules, and turnaround commitments across the contract testing network. - Provides leadership and oversight for implementation of the analytical control strategy and specifications at the contract manufacturing and contract testing organizations, as set through project team governance. - Oversight on reviews and approval of vendor documents supporting execution, including sampling plans, change controls, and test methods. - Ensures that QC operations deliver batch release through certificate of analysis generation and timely review and approval of analytical results. - Ensures on-time testing and release so that manufacturing and supply commitments are met. - Vendor Collaboration and Oversight - Acts as the main Global Analytical contact for QC routine operation with contract manufacturing and contract testing organizations. - Runs day-to-day operational oversight of external laboratories, including performance against agreed turnaround, quality, and compliance expectations. - Strengthens vendor collaboration through dedicated and focused working sessions and escalates commercial and contractual matters to Global Analytics and Technical Operations. - Quality Events, Investigations, and Data - Takes ownership of cross-component quality incidents related to analytics, including deviations, laboratory investigations, and out-of-specification and out-of-trend results, driving them to root-cause-based closure with corrective and preventive actions. - Ensures that QC Operations takes ownership or provide support on quality incidents related to analytics, including deviations, laboratory investigations, and out-of-specification and out-of-trend results, driving them to root-cause-based closure with corrective and preventive actions. - Owns trending of analytical data related to release and escalates emerging risk to the Head of Quality Control and the relevant Analytical Technical Lead. - Ensures data integrity principles are applied in all QC activities in compliance with Vaxcyte policies, guidelines, and procedures. - Controlled Documentation and Compliance - Authors and maintains the QC policies, standard operating procedures, work instructions, and templates that describe how QC operates today, and keeps them current as the process changes. - Ensures QC activities comply with cGMP, global regulatory requirements, and internal standards. - Implements the QC framework and governance developed for commercial readiness into routine QC practice. - Audit and Inspection Support - Supports regulatory inspections, pre-approval inspection readiness, and customer and partner audits with QC due diligence, documentation, and subject matter expertise. - Ensures QC records, results, and investigations are complete, retrievable, and defensible. - Team Leadership and Capability - Takes ownership of QC operations training curricula and status of training. - Leads, develops, and coaches the QC Operations team across sites and time zones, setting clear priorities and performance expectations. - Plans QC Operations resources in alignment with manufacturing and testing schedules so that analytical deliverables and testing are carried out to quality standards. - Builds a culture of accountability, learning, and collaboration, and partners with Quality Assurance as one quality unit. Requirements: - Bachelor of Science with 10+ years of relevant experience in the biotechnology or pharmaceutical industry. - Direct leadership of a GMP quality control function, including line management of a QC team. - Experience managing and overseeing contract laboratories and contract manufacturing organizations, including performance monitoring. - Comprehensive knowledge of cGMPs and multi-national regulations. - Demonstrated ownership of deviations, out-of-specification investigations, and corrective and preventive actions in a GMP laboratory setting. - Experience supporting regulatory inspections and partner audits from a quality control standpoint. - Experience authoring GMP controlled documents, including standard operating procedures, work instructions, and templates. - Excellent communication, negotiation, and relationship-building skills, with the ability to collaborate effectively with internal and external stakeholders. - Strong organizational, management, teamwork, and interpersonal skills, and professionalism required. - Relentless focus and passion around process improvements, efficiency, and automation. - Vaccine or conjugate vaccine experience preferred. Reports to: Senior Director, Quality Control Location: Visp, Switzerland Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy): Hybrid (minimum of 3 days per week onsite) Compensation: The compensation package will be competitive and includes comprehensive benefits and an equity component. Relocation: This role is not eligible for relocation assistance. ## Equal Opportunity We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status. Recruitment Fraud Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at [vaxcyte.com/careers](https://vaxcyte.com/careers/). ## About Vaxcyte ## Company Overview - **One-liner**: Vaxcyte is a clinical-stage biotechnology company re-engineering how vaccines are made to eliminate bacterial infections, using a cell-free protein synthesis platform to develop high-fidelity, broad-spectrum vaccines. - **Entity Type**: Public (Ticker: PCVX) - **Headquarters**: San Carlos, California, United States - **Founded**: 2013 (as SutroVax; rebranded to Vaxcyte in 2020) - **Founders**: Not publicly available (the company emerged from Sutro Biopharma’s spin-out) ## Core Business - **Primary industry**: Biotechnology / Vaccines (Infectious Disease) - **Target customers**: Global healthcare systems, public health organizations, and ultimately patients (B2B/Institutional); the company develops vaccines for both pediatric and adult populations. - **Mission or purpose**: To protect humankind from the consequences of bacterial infections, eliminating diseases like invasive pneumococcal disease, Group A Strep, and Shigella. ## Products & Services - **VAX-31 (31-valent PCV)**: A broad-spectrum pneumococcal conjugate vaccine candidate in Phase 3 for adults and Phase 2 for infants. Designed to cover over 95% of circulating IPD serotypes in U.S. adults 50+ and ~94% in infants. FDA Breakthrough Therapy designation granted. - **VAX-24 (24-valent PCV)**: A pneumococcal conjugate vaccine candidate in Phase 2 for infants, designed to cover more serotypes than any infant PCV on the market today. - **VAX-A1 (Group A Strep)**: A preclinical conjugate vaccine candidate for Group A Strep, a disease with no currently approved vaccine. Phase 1 first-in-human study (adults) underway in Australia. - **VAX-GI (Shigella)**: A novel preclinical vaccine candidate targeting Shigella, a leading cause of diarrheal disease. - **Platform Technology**: A proprietary cell-free protein synthesis platform that enables site-specific, carrier-sparing conjugation to produce precisely targeted vaccines with enhanced immunogenicity. ## Market Standing - **Valuation/Market Cap**: ~$16.7 billion (as of early July 2026) - **Key Metric**: Total funding raised (private) is not applicable; as a public company, key metrics include cash position (~$2.0 billion as of Q1 2026) and R&D investment. The company is pre-revenue. - **Notable Investors/Partners**: Major institutional investors include Baker Bros. Advisors, Fidelity, and funds managed by BlackRock. Key partnership: exclusive license agreement with Sutro Biopharma for its cell-free protein synthesis platform. - **Growth Signals**: - Up to $1 billion commitment to expanding U.S. manufacturing with a new facility in North Carolina. - VAX-31 Phase 3 program (OPUS-1, OPUS-2, OPUS-3) topline data expected Q4 2026 – H1 2027. - Headcount growth: actively hiring across 100+ roles (Analytical, Commercial, Clinical, Conjugation, Quality, Regulatory). - Recognized as a Great Place to Work and Best Workplace in BioPharma (multiple years). ## Competitive Advantages - **Broadest-spectrum PCV candidates**: VAX-31 is the broadest-spectrum pneumococcal conjugate vaccine in the clinic, targeting up to 31 serotypes. - **Differentiated platform**: Cell-free protein synthesis allows for the creation of complex, high-fidelity vaccines that can overcome bacterial defense mechanisms (e.g., capsule-switching) that limit conventional cell-based vaccines. - **Carrier-sparing technology**: Site-specific conjugation enables a higher valency (more serotypes) without compromising immunogenicity or tolerability. - **Manufacturing scale**: Significant investment in U.S.-based production capacity provides a long-term supply chain advantage and aligns with "Investing in America" initiatives. ## Strategic Focus - **Primary**: Advance VAX-31 and VAX-24 through late-stage clinical trials to secure regulatory approval and establish a new standard of care for pneumococcal disease. - **Pipeline expansion**: Advance VAX-A1 (Group A Strep) and VAX-GI (Shigella) candidates through early clinical development. - **Manufacturing**: Scale up internal manufacturing capabilities to support commercial launch and global supply. - **Commercial readiness**: Building a commercial organization (e.g., hiring a VP of U.S. Market Access & Pricing, Senior Director of Product Launch) to prepare for potential VAX-31 launch. ## Why Work Here - **Culture**: Described as a "kindness-first" mindset with a focus on audacious goals, collaboration, and mutual support. Recognized as a *Great Place to Work* and *Best Workplace in BioPharma* (Fortune). - **Work Model**: Hybrid, Remote, and Onsite options available depending on role. San Carlos HQ offers a hybrid schedule. - **Total Rewards**: 100% paid health, dental, and vision insurance; 401k matching; flexible PTO and holidays; paid parental and sick leave; equity awards (stock options & RSUs); Employee Stock Purchase Plan; lifestyle spending account; mental health and wellness resources. - **Growth & Development**: Strong emphasis on learning culture, professional advancement through coaching, and career development programs. - **Mission-driven**: Employees are directly contributing to creating vaccines that protect every child born and every adult at risk from bacterial infections globally. ## Sources 1. [vaxcyte.com](https://vaxcyte.com/) 2. [vaxcyte.com/careers](https://vaxcyte.com/careers/) 3. [vaxcyte.com/job-listings](https://vaxcyte.com/job-listings/) 4. [vaxcyte.com/culture](https://vaxcyte.com/culture/) 5. [vaxcyte.com/pipeline](https://vaxcyte.com/pipeline/) ## Other roles at Vaxcyte - [Process Engineer I, Data and Knowledge Management](https://feeny.ai/job/process-engineer-i-data-and-knowledge-management-vaxcyte-san-carlos-a2fbd5dqkav5) — San Carlos, CA - [Executive Assistant](https://feeny.ai/job/executive-assistant-vaxcyte-san-carlos-cc1yzaynf06a) — San Carlos, CA - [Director, Global Drug Substance Commercialization, Polysaccharide](https://feeny.ai/job/director-global-drug-substance-commercialization-polysaccharide-vaxcyte-san-rvfmdcgec6sk) — San Carlos, CA - [Associate Director, Business Operations & Digital Enablement](https://feeny.ai/job/associate-director-business-operations-digital-enablement-vaxcyte-san-carlos-1cv5813jhces) — San Carlos, CA - [Associate Director, Business Process Management & Operational Excellence](https://feeny.ai/job/associate-director-business-process-management-operational-excellence-vaxcyte-5p0t7q2tj3a5) — San Carlos, CA - [Manager Accounting , Inventory and Operations](https://feeny.ai/job/manager-accounting-inventory-and-operations-vaxcyte-san-carlos-r66rjpkp6y1a) — San Carlos, CA - [Senior Accountant](https://feeny.ai/job/senior-accountant-vaxcyte-san-carlos-j4sqgfxb13nj) — San Carlos, CA - [Systems Engineer](https://feeny.ai/job/systems-engineer-vaxcyte-san-carlos-zy2wf03ynbzs) — San Carlos, CA - [IT Operations Engineer](https://feeny.ai/job/it-operations-engineer-vaxcyte-san-carlos-y9kstk4b8rz9) — San Carlos, CA - [Manager, Facilities Engineering](https://feeny.ai/job/manager-facilities-engineering-vaxcyte-san-carlos-9z48ebpsa6x8) — San Carlos, CA